Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Aphria

Canopy Growth

Cronos Group

HEXO Corp

OrganiGram Holdings Inc.

SNDL Inc.

With Canadian pot sales expected to hit $5 billion annually by 2024, it pays to know the biggest names in the industry.

The 10 Largest Canadian Marijuana Stocks

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Options Traders Expect Huge Moves in Tilray (TLRY) Stock

Amplify Alternative Harvest ETF

Some cannabis stocks are seeing their prices surge as investors hunt for winners in the ashes of an industry shakeout that hammered share prices last year.

Bargain hunters fire up rally in cannabis stocks

Why CBD Stocks Could Soon Skyrocket

Among the marijuana losers of 2019, Tilray stock was one of the ugliest. However, with executive-level recruitments, along with a clearer roadway, this name can surprise investors.

This Surge in Tilray Stock May Not Be a One-off Event

When Canadian cannabis grower Tilray Inc. (NASDAQ: TLRY) came public in the United States in July of 2018, the company’s initial public offering priced at $17 a share, above the expected range of $14 to $16.

Can Tilray Stock Make a Comeback?

MedMen Enterprises Inc.

The green rush has been anything but "green" for these cannabis companies.

5 of the Most Popular Pot Stocks Won't Be Profitable Until 2022 (at the Earliest)

Delta Air Lines

Tilray rose on news of two new executive hires, while Delta Air Lines reported an encouraging Q4.

2 Stocks That Topped the Market on Tuesday

Two new hires spark hope for a revival in sales growth.

Why Tilray Stock Popped 22.2% Today

Corporate veterans from different industries are joining this cannabis giant.

Tilray Announces Major Executive Changes, Molson Coors Exec as CFO

Canadian cannabis company Tilray Inc. TLRY, +11.70% said Tuesday it has named former Molson Coors executive Michael Kruteck as its chief financial officer, replacing Mark Castaneda, who will take on the role of strategic business development.

Tilray names ex-Molson Coors executive Michael Kruteck as CFO

One exception to the list of big winners: Aurora Cannabis.

Why Canopy Growth, Cronos Group, and Most Other Top Canadian Pot Stocks Are Jumping Today

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

GW Pharmaceuticals

Trulieve Cannabis Corp.

Following a disastrous 2019 for the cannabis industry, only nine pot stocks still boast billion-dollar valuations.

The 10 Largest Marijuana Stocks in 2020

CannTrust Holdings

These marijuana stocks looked great on paper when the year began but were absolute disasters when the curtain closed.

3 Popular Cannabis Stocks That Imploded in 2019

There could be a lot more hemp-based CBD products on store shelves this year.

2 Stocks That Could Dominate the Hemp CBD Space in 2020

The internationally focused company says the Middle Eastern nation will be its 15th export market.

Tilray to Ship First-Ever Commercial Medical Pot Delivery to Israel

Tilray Inc. TLRY, -2.98% announced Thursday a deal with InterCure Ltd. INCR, +5.21% IRCLF, +5.65% subsidiary Canndoc Ltd.

Tilray to ship 2.5 million tonnes of medical cannabis to Israel

Tilray (TLRY) shares rose 9% in the last trading session, amid huge volumes.

Tilray (TLRY) in Focus: Stock Moves 9% Higher

Tailwinds are on the way for these beaten-down marijuana stocks. But some key problems will persist, too.

Are Aurora Cannabis, HEXO, and Tilray Ready to Rebound in 2020?

As a dismal 2019 comes to an end, investors appear to be looking to a brighter 2020.

Why Aurora Cannabis, Canopy Growth, and Other Top Canadian Marijuana Stocks Soared Today

New Age Beverages

Constellation Brands

The political winds could shift regarding U.S. legalization.

1 Reason Marijuana Stocks Could Bounce Back in 2020

Which cannabis stock is likely to have a better year in 2020?

Better Buy: Cronos vs. Tilray

Being a cannabis stock pessimist was a profitable venture this year.

Short Sellers Made $791 Million in 2019 by Betting Against These 4 Pot Stocks

Major pot producers and their beer partners have a full lineup of CBD drinks poised to hit store shelves.

Canopy, HEXO, and Tilray Have Marijuana Drinks Ready to Roll in Canada

Collectively, investors lost almost $10 billion on these pot stocks since the year began.

News for Tilray Brands Stock (TLRY)